Advisory Research Inc Cytokinetics Inc Transaction History

Advisory Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $465,370 - $658,329	-12,075 Reduced 32.74%	24,808 $1.2 Million
Q2 2022 Aug 17, 2022	SELL	$33.93 - $48.92 $96,666 - $139,373	-2,849 Reduced 7.17%	36,883 $1.45 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $91,777 - $141,956	-3,086 Reduced 7.21%	39,732 $1.46 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $335,152 - $452,529	9,757 Added 29.51%	42,818 $1.95 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $612,950 - $1.18 Million	33,061 New	33,061 $1.18 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.